Wen Wen Low

Wen Wen Low

Auto-generated profile, based on publicly available information

Wen Wen Low

Infectious Diseases Translational Research Programme, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
WLWen Wen Low
Wen Wen Low
JWJoshua L. C. Wong
Joshua L. C. Wong
LBLeticia C. Beltran
Leticia C. Beltran
CSChloe Seddon
Chloe Seddon
SDSophia David
Sophia David
GFGad Frankel
Gad Frankel
Bacterial conjugation mediates contact-dependent transfer of DNA from donor to recipient bacteria, thus facilitating the spread of virulence and resistance plasmids. Here we describe how variants of the plasmid-encoded donor outer membrane (OM) protein TraN cooperate with distinct OM receptors in recipients to mediate mating pair stabilization and efficient DNA transfer. We show that TraN from the plasmid pKpQIL ( Klebsiella pneumoniae ) interacts with OmpK36, plasmids from R100-1 ( Shigella flexneri ) and pSLT ( Salmonella Typhimurium) interact with OmpW, and the prototypical F plasmid ( Escherichia coli ) interacts with OmpA. Cryo-EM analysis revealed that TraN pKpQIL interacts with OmpK36 through the insertion of a β-hairpin in the tip of TraN into a monomer of the OmpK36 porin trimer. Combining bioinformatic analysis with AlphaFold structural predictions, we identified a fourth TraN structural variant that mediates mating pair stabilization by binding OmpF. Accordingly, we devised a classification scheme for TraN homologues on the basis of structural similarity and their associated receptors: TraNα (OmpW), TraNβ (OmpK36), TraNγ (OmpA), TraNδ (OmpF). These TraN-OM receptor pairings have real-world implications as they reflect the distribution of resistance plasmids within clinical Enterobacteriaceae isolates, demonstrating the importance of mating pair stabilization in mediating conjugation species specificity. These findings will allow us to predict the distribution of emerging resistance plasmids in high-risk bacterial pathogens.

12 September 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JWJoshua L. C. Wong
Joshua L. C. Wong
SDSophia David
Sophia David
JSJulia Sanchez-Garrido
Julia Sanchez-Garrido
JWJia Z. Woo
Jia Z. Woo
WLWen Wen Low
Wen Wen Low
GFGad Frankel
Gad Frankel
Outer membrane porins in Gram-negative bacteria facilitate antibiotic influx. In Klebsiella pneumoniae , modifications in the porin OmpK36 are implicated in increasing resistance to carbapenems. An analysis of large K. pneumoniae genome collections, encompassing major healthcare-associated clones, revealed the recurrent emergence of a synonymous cytosine-to-thymine transition at position 25 (25c > t) in ompK36. We show that the 25c > t transition increases carbapenem resistance through depletion of OmpK36 from the outer membrane. The mutation attenuates K. pneumoniae in a murine pneumonia model, which accounts for its limited clonal expansion observed by phylogenetic analysis. However, in the context of carbapenem treatment, the 25c > t transition tips the balance toward treatment failure, thus accounting for its recurrent emergence. Mechanistically, the 25c > t transition mediates an intramolecular messenger RNA (mRNA) interaction between a uracil encoded by 25t and the first adenine within the Shine–Dalgarno sequence. This specific interaction leads to the formation of an RNA stem structure, which obscures the ribosomal binding site thus disrupting translation. While mutations reducing OmpK36 expression via transcriptional silencing are known, we uniquely demonstrate the repeated selection of a synonymous ompK36 mutation mediating translational suppression in response to antibiotic pressure.

10 September 2020 in Structure
Verified
Journal Article
Closed access
WZWeili Zheng
Weili Zheng
APAlejandro Pena
Alejandro Pena
WLWen Wen Low
Wen Wen Low
JWJoshua L.C. Wong
Joshua L.C. Wong
GFGad Frankel
Gad Frankel
EEEdward H. Egelman
Edward H. Egelman

10 December 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MYMelvin Yong
Melvin Yong
WLWen Wen Low
Wen Wen Low
SMSwapnil Mishra
Swapnil Mishra
GWGalain Williams
Galain Williams
SMSteven Mileto
Steven Mileto
YGYunn Hwen Gan
Yunn Hwen Gan
Conjugative plasmids can drive the global spread of antimicrobial resistance (AMR) in Enterobacterales. Hypervirulent Klebsiella pneumoniae (hvKp) increasingly acquire AMR plasmids, raising concern about convergent hypervirulent drug-resistant clones. Yet little is known about plasmid transmission dynamics in hvKp. Using an antibiotic-perturbed murine gut model with hvKp and human commensal E. coli, we discover that broad-host range IncP plasmids belonging to different phylogenetic branches (clade I (PTU-P1) and clade II (PTU-P2)) transfer differentially in the gut, mirroring the higher prevalence of PTU-P2 plasmids in human-associated samples. Statistical modelling and experimental results show that secondary transfer by transconjugants sustains gut transmission without continuous donor input. Furthermore, the hvKp capsule exerts a modest effect on transfer in vivo compared to in vitro aerobic conditions. Under anaerobic conditions, hvKp capsule mucoviscosity is markedly reduced, and PTU-P2 plasmids conjugate more efficiently than PTU-P1 counterparts. Our findings reveal that the hypermucoviscous capsule may not substantially impede gene exchange in the gut where microenvironments shape plasmid transfer dynamics, highlighting the pitfalls of extrapolating in vitro data to relevant ecological niches. Our work also emphasizes the high-risk nature of gut-adapted PTU-P2 plasmids and the ease with which hvKp can acquire them, underscoring the need for continued surveillance.

11 August 2025 in bioRxiv
Verified
Preprint
Open access
YWYu Wan
Yu Wan
JWJoshua L. C. Wong
Joshua L. C. Wong
JSJulia Sanchez-Garrido
Julia Sanchez-Garrido
WLWen Wen Low
Wen Wen Low
JTJane F. Turton
Jane F. Turton
KHKatie Hopkins
Katie Hopkins
This article reports an unusual Klebsiella pneumoniae clinical isolate, KpMVR1, resistant to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam, and investigates the underlying genetic alterations using comparative genomics and molecular experiments. Resistance to carbapenems and third-generation cephalosporins is increasing in K. pneumoniae globally, restricting therapeutic options. The β-lactam/β-lactamase inhibitor combinations are widely used to circumvent β-lactamase-mediated resistance. In 2021, isolate KpMVR1 was recovered from a hospitalised patient in England. Two additional isolates with the same variable-number tandem-repeat profile—KpMVS1, collected from the same patient 42 days before KpMVR1, and KpMVS2, from another patient in the same hospital—were susceptible to meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam. Illumina and nanopore whole-genome sequencing and hybrid genome assembly were conducted for these three isolates. Annotated genome assemblies were compared to identify genetic variation, and mutagenesis experiments were performed to verify predicted functional alterations. All isolates belonged to a novel clone ST8134 and carried bla KPC-2 -like alleles (KpMVR1: bla KPC-157 ; KpMVS1 and KpMVS2: bla KPC-2 ) in presumptively conjugative plasmids. IS Ec68 caused a frameshift mutation in KpMVR1’s ompK36 gene, reducing the meropenem-vaborbactam and imipenem-relebactam susceptibility. KPC-157 demonstrated decreased hydrolysis of imipenem and ceftazidime when compared with KPC-2. KpMVR1 also encoded a disrupted transcriptional repressor MarR and a destabilising mutation in AcrB, a component of the AcrAB-TolC multidrug efflux pump. In conclusion, KpMVR1 harboured complex resistance-associated genetic alterations, with evidence for in vivo emergence of antimicrobial resistance. Our study underlines routine screening for resistant pathogens in vulnerable patients to guide antimicrobial chemotherapy as well as the need to characterise underlying resistance mechanisms to help assess the potential for onward transmission. Data summary: Illumina and nanopore sequencing reads, hybrid genome assemblies, and anonymised metadata of isolates KpMVS1, KpMVR1, and KpMVS2 have been deposited in databases of the National Center for Biotechnology Information ( www.ncbi.nlm.nih.gov ) under BioProject accession PRJNA1084250, with BioSample accessions SAMN46778009 (KpMVS1), SAMN46778010 (KpMVR1), and SAMN46778011 (KpMVS2). The genome assemblies of these isolates have also been deposited in Pasteur Institute’s database for K. pneumoniae species complex ( bigsdb.pasteur.fr/klebsiella/ ) under ids 75608 (KpMVS1), 75609 (KpMVR1), and 75610 (KpMVS2). Impact statement: This is the first bla KPC -positive K. pneumoniae isolate referred to the UK’s national reference laboratory with resistance to three last-resort β-lactam/β-lactamase inhibitor combinations meropenem-vaborbactam, imipenem-relebactam, and ceftazidime-avibactam, implicating in vivo emergence of this unusual resistance profile during prolonged antimicrobial chemotherapy. This isolate belonged to a novel clone ST8134 and harboured a plasmid-borne bla KPC-2 -like allele bla KPC-157 . We identified complex genetic alterations in this isolate: chromosomal large deletions, point mutations, and an IS Ec68 -induced loss-of-function truncation of the ompK36 porin gene. We determined the impact of KPC-2, KPC-157, and the ompK36 truncation on the susceptibility of K. pneumoniae to meropenem, meropenem-vaborbactam, imipenem, imipenem-relebactam, imipenem-avibactam, aztreonam, aztreonam-avibactam, ceftazidime, ceftazidime-avibactam, and cefiderocol. Our work underscores the need to monitor emerging resistance to beta-lactam/beta-lactamase inhibitor combinations in healthcare and to understand underlying resistance mechanisms for assessing the potential of resistance transmission.